Pregled bibliografske jedinice broj: 587698
Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl4-intoxicated mice is mediated by up-regulation of MMP-2 expression
Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl4-intoxicated mice is mediated by up-regulation of MMP-2 expression // Journal of medicinal food, 16 (2013), 6; 518-528 doi:10.1089/jmf.2012.0175 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 587698 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl4-intoxicated mice is mediated by up-regulation of MMP-2 expression
Autori
Domitrović, Robert ; Jakovac, Hrvoje ; Vasiljev Marchesi, Vanja ; Blažeković, Biljana
Izvornik
Journal of medicinal food (1096-620X) 16
(2013), 6;
518-528
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
liver fibrosis; berberine; tumor necrosis factor-α; transforming growth factor-β1; α-smooth muscle actin; matrix metalloproteinase
Sažetak
Liver fibrosis is a result of chronic liver injury and represents a widespread medical problem. The aim of this study was to investigate the antifibrotic activity of isoquinoline alkaloid berberine in carbon tetrachloride (CCl4)-induced damage in mice. The hepatoprotective activity of bereberine was compared to the reference drug silymarin. Hepatic fibrosis was induced by intraperitoneal (i.p.) administration of CCl4 (2 ml/kg, 20% v/v in olive oil) twice a week for 8 weeks. Berberine in doses of 3 and 9 mg/kg and silymarin in dose of 50 mg/kg were given i.p. once daily for next 2 weeks. CCl4-intoxication induced elevation of serum transaminases and oxidative stress in the livers. Hepatic fibrosis was evidenced by massive deposition of collagen, which coincided with increased expression of the tumor necrosis factor (TNF)-α and transforming growth factor (TGF)-β1 in the livers and activation of hepatic stelate cells (HSCs). The high-dose berberine (9 mg/kg) ameliorated oxidative stress, decreased the TNF-α and TGF-β1 expression, increased the matrix metalloproteinase (MMP)-2 levels and stimulated elimination of fibrotic deposits. Berberin in dose of 9 mg/kg exhibited stronger therapeutic activity against hepatic fibrosis than silymarin 50 mg/kg. The results of this study suggest that berberine could be used for treatment of liver fibrosis through down-regulation of hepatic fibrogenic potential and stimulation of degradation of collagen deposits by MMP-2.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Farmacija
POVEZANOST RADA
Projekti:
062-0000000-3554 - Aktivni sastojci ljekovitog bilja u terapiji fibroze jetre (Domitrović, Robert, MZOS ) ( CroRIS)
Sveučilište u Rijeci
potpora 13.06.1.2.24
006-0061117-1238 - Bioaktivne prirodne tvari: izolacija, karakterizacija i biološki učinci (Vladimir-Knežević, Sanda, MZOS ) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Medicinski fakultet, Rijeka
Profili:
Vanja Vasiljev (autor)
Biljana Blažeković (autor)
Robert Domitrović (autor)
Hrvoje Jakovac (autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE